February 22, 2019 / 3:59 PM / 9 months ago

BUZZ-Trillium Therapeutics: Plunges after pricing offering of units

** U.S.-listed shares of Canadian drug developer plunge 37.5 pct to 74 cents; stock third biggest pct loser across all U.S. exchanges

** Co prices its offering of 6.55 mln common share units and 12.2 mln preferred share units at 80 cents

** Expected gross proceeds of about $15 mln to be used for ongoing research on cancer treatment and general corporate purposes - TRIL

** Stock had fallen 81 pct in the past year (Reporting by Manas Mishra in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below